Literature DB >> 15812308

Medullary N-type and P/Q-type calcium channels contribute to neuropathy-induced allodynia.

Mark O Urban1, Kunkun Ren, Marciano Sablad, Kenneth T Park.   

Abstract

The present study was designed to determine the contribution of N-type, P/Q-type and L-type calcium channels in the rostral ventromedial medulla to tactile allodynia following peripheral nerve injury. L5/L6 spinal nerve ligation in rats produced tactile allodynia, which was dose-dependently inhibited by intrarostral ventromedial medulla microinjection of the N-type calcium channel antagonist omega-conotoxin MVIIA. Similarly, intrarostral ventromedial medulla microinjection of the P/Q-type calcium channel antagonist omega-agatoxin IVA inhibited spinal nerve ligation-induced tactile allodynia, whereas intrarostral ventromedial medulla microinjection of the L-type calcium channel antagonist nimodipine had no effect. These results demonstrate that N-type and P/Q-type calcium channels in the rostral ventromedial medulla contribute to tactile allodynia following peripheral neuropathy, likely via neurotransmitter-mediated activation of descending facilitatory systems from the rostral ventromedial medulla.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812308     DOI: 10.1097/00001756-200504250-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  Differential effects of voltage-gated calcium channel blockers on calcium channel alpha-2-delta-1 subunit protein-mediated nociception.

Authors:  E Chang; X Chen; M Kim; N Gong; S Bhatia; Z D Luo
Journal:  Eur J Pain       Date:  2014-08-27       Impact factor: 3.931

Review 2.  Targeting chronic and neuropathic pain: the N-type calcium channel comes of age.

Authors:  Terrance P Snutch
Journal:  NeuroRx       Date:  2005-10

3.  Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.

Authors:  Timothy A Vortherms; Andrew M Swensen; Wende Niforatos; James T Limberis; Torben R Neelands; Richard S Janis; Rama Thimmapaya; Diana L Donnelly-Roberts; Marian T Namovic; Di Zhang; C Brent Putman; Ruth L Martin; Carol S Surowy; Michael F Jarvis; Victoria E Scott
Journal:  Inflamm Res       Date:  2011-03-11       Impact factor: 4.575

Review 4.  Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine.

Authors:  Daniela Pietrobon
Journal:  J Physiol       Date:  2010-03-01       Impact factor: 5.182

5.  Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression.

Authors:  Tetsuji Terashima; Qinghao Xu; Shigeki Yamaguchi; Tony L Yaksh
Journal:  Neuropharmacology       Date:  2013-06-26       Impact factor: 5.250

Review 6.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

7.  Electrophysiological characterization of activation state-dependent Ca(v)2 channel antagonist TROX-1 in spinal nerve injured rats.

Authors:  R Patel; K Rutten; M Valdor; K Schiene; S Wigge; S Schunk; N Damann; T Christoph; A H Dickenson
Journal:  Neuroscience       Date:  2015-04-01       Impact factor: 3.590

Review 8.  Calcium channel modulation as a target in chronic pain control.

Authors:  Ryan Patel; Carlota Montagut-Bordas; Anthony H Dickenson
Journal:  Br J Pharmacol       Date:  2017-04-26       Impact factor: 8.739

9.  Ziconotide: a review of its pharmacology and use in the treatment of pain.

Authors:  Joseph G McGivern
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

Review 10.  Familial hemiplegic migraine.

Authors:  Daniela Pietrobon
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.